• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肺结节病:当前的诊断与治疗]

[Pulmonary sarcoidosis: current diagnosis and treatment].

作者信息

Kirsten D

机构信息

Ambulanz für Seltene Lungenkrankheiten und Sarkoidose an der LungenClinic Grosshansdorf, Großhansdorf, Germany.

出版信息

Dtsch Med Wochenschr. 2013 Mar;138(11):537-41. doi: 10.1055/s-0032-1332898. Epub 2013 Mar 5.

DOI:10.1055/s-0032-1332898
PMID:23463476
Abstract

Sarcoidosis is a multisystemic granulomatous disorder of unknown origin, which can involve multiple organs. However the lymph node and lung manifestations dominate. Most frequent symptoms are cough, fatigue, dyspnea and exercise limitations. About one third of the patients have no symptoms. The lung function test is mostly restrictive. The clinical course is very variable, spontaneous remissions occur in about 60 %. Acute sarcoidosis is a highly inflammatory disease with a very good prognosis even without steroid therapy. Chronic pulmonary sarcoidosis can lead to progressive loss of lung function. Indications to therapy are severe symptoms and loss of lung function as well as progressive lung involvement with fibrosis pattern. In chronic disease corticosteroids are effective in the majority of patients. Other immunosuppressives, cytotoxic and immunomodulatory agents are reserved for patients with severe side-effects to steroid-therapy or for patients, who cannot maintained on reasonable low doses of steroids. Lung transplantation is an option for life-threatening cases failing medical therapy.

摘要

结节病是一种病因不明的多系统肉芽肿性疾病,可累及多个器官。然而,淋巴结和肺部表现最为常见。最常见的症状是咳嗽、疲劳、呼吸困难和运动受限。约三分之一的患者没有症状。肺功能测试大多显示为限制性通气功能障碍。临床病程差异很大,约60%的患者会自发缓解。急性结节病是一种高度炎症性疾病,即使不进行类固醇治疗,预后也很好。慢性肺部结节病可导致肺功能逐渐丧失。治疗指征为严重症状、肺功能丧失以及肺部出现进行性纤维化改变。在慢性病中,大多数患者使用皮质类固醇有效。其他免疫抑制剂、细胞毒性药物和免疫调节剂则用于对类固醇治疗有严重副作用的患者或无法维持合理低剂量类固醇治疗的患者。对于药物治疗无效的危及生命的病例,肺移植是一种选择。

相似文献

1
[Pulmonary sarcoidosis: current diagnosis and treatment].[肺结节病:当前的诊断与治疗]
Dtsch Med Wochenschr. 2013 Mar;138(11):537-41. doi: 10.1055/s-0032-1332898. Epub 2013 Mar 5.
2
Pulmonary sarcoidosis.肺结节病
Semin Respir Crit Care Med. 2007 Feb;28(1):53-74. doi: 10.1055/s-2007-970333.
3
Pulmonary sarcoidosis.肺结节病
Clin Chest Med. 2008 Sep;29(3):459-73, viii-ix. doi: 10.1016/j.ccm.2008.03.002.
4
Sarcoidosis: is therapy effective?结节病:治疗是否有效?
Semin Respir Infect. 1998 Sep;13(3):255-73.
5
Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes.结节病性肺纤维化。临床特征和结局。
Ann Am Thorac Soc. 2013 Aug;10(4):362-70. doi: 10.1513/AnnalsATS.201303-069FR.
6
Contemporary optimized practice in the management of pulmonary sarcoidosis.当代肺结节病管理中的优化实践。
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619868935. doi: 10.1177/1753466619868935.
7
Intrathoracic sarcoidosis.胸内结节病
Dis Mon. 2009 Nov;55(11):661-74. doi: 10.1016/j.disamonth.2009.04.009.
8
Treatments for pulmonary sarcoidosis.肺结节病的治疗方法。
Respir Med. 2008 Jan;102(1):1-9. doi: 10.1016/j.rmed.2007.08.010. Epub 2007 Oct 22.
9
Pulmonary sarcoidosis: an update.肺结节病:最新进展
Postgrad Med. 2017 Jan;129(1):149-158. doi: 10.1080/00325481.2017.1251818. Epub 2016 Nov 2.
10
Pulmonary sarcoidosis: diagnostic and treatment update.肺结节病:诊断与治疗进展。
Expert Rev Respir Med. 2014 Aug;8(4):493-501. doi: 10.1586/17476348.2014.919225. Epub 2014 May 16.

引用本文的文献

1
Immune Mechanisms of Pulmonary Fibrosis with Bleomycin.博来霉素致肺纤维化的免疫机制。
Int J Mol Sci. 2023 Feb 5;24(4):3149. doi: 10.3390/ijms24043149.
2
The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis.结节病的诊断、鉴别诊断及治疗
Dtsch Arztebl Int. 2016 Aug 22;113(33-34):565-74. doi: 10.3238/arztebl.2016.0565.
3
Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.氟非尼酮通过抑制NALP3炎性小体和IL-1β/IL-1R1/MyD88/NF-κB信号通路的激活来减轻肺部炎症和纤维化。
J Cell Mol Med. 2016 Nov;20(11):2064-2077. doi: 10.1111/jcmm.12898. Epub 2016 Jun 16.
4
[Sarcoidosis : Organ involvement, diagnosis, current treatment].[结节病:器官受累、诊断及当前治疗]
Hautarzt. 2015 Jul;66(7):549-63. doi: 10.1007/s00105-015-3646-5.
5
Epigenetics in immune-mediated pulmonary diseases.免疫介导性肺部疾病中的表观遗传学。
Clin Rev Allergy Immunol. 2013 Dec;45(3):314-30. doi: 10.1007/s12016-013-8398-3.